Arshjot Khokhar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Arshjot Khokhar has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Pritish Mondal
Department of Pediatrics, Penn State College of Medicine, Hershey, PA, United States
3 shared publications A. Sinharoy
Public Health, Penn State College of Medicine, Hershey, PA, United States
2 shared publications- Alexandra Schwann
Yale-New Haven Hospital
2 shared publications - Marah Maayah
Department of Psychiatry and Women’s Health Research at Yale Yale University School of Medicine New Haven CT
2 shared publications Mutasim Abu‐Hasan
Department of Pediatrics, Division of Pulmonology, University of Florida, Gainesville, Florida, USA
2 shared publications- Natalija Odanovic
Institute for Cardiovascular Diseases "Dedinje", Belgrade, Serbia
2 shared publications
Latest Publications
- Open Access
- 1 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (19) , e035852
Diagnostic Yield and Clinical Utility of Coronary Angiography Versus Coronary Function Testing in Women With Angina and Nonobstructive Coronary Arteries
Background: Approximately 50% of women referred for invasive coronary angiography have angina and nonobstructive coronary arteries, which includes coronary microvascular dysfunction, vasospastic angina, and other vasomotor disorders. We sought to determine the real‐world diagnostic yield of invasive coronary angiography and coronary function testing in women with angina and nonobstructive coronary arteries. Methods and Results: From 2018 to 2023, we enrolled 198 women who underwent either coronary angiography (CA) alone (n=99) or coronary function testing (CFT; n=99). Mean±SD age was 62±10 years (CA alone) compared with 57±10 years (CFT). Coronary angiography was interpreted as nonobstructive coronary artery disease more frequently after CA alone (79% versus 52%). Of the women who underwent CFT, 82% (N=81) were found to have vasomotor disorders, including coronary microvascular dysfunction (27%), vasospastic angina (32%), mixed coronary microvascular dysfunction/vasospastic angina (16%), endothelial dysfunction (10%; without spasm), elevated resting flow (2%), or symptomatic myocardial bridging (4%). Compared with women undergoing CA alone, medications were changed more frequently after CFT at 24 hours (41% versus 65%; P =0.001) and between 24 hours and 30 days (30% versus 44%; P =0.04) with intensification of antianginal therapy (79% versus 92%; P< 0.0001) and increased use of calcium channel blockers (36% versus 63%; P< 0.0001). Conclusions: Our findings demonstrate that women presenting with suspected ischemic heart disease undergoing CA alone only received an anatomic diagnosis, whereas >80% of women undergoing CFT received a specific diagnosis of a coronary vasomotor disorder and greater intensification of antianginal therapy.
- 1 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (19) , e035852
Open AccessDiagnostic Yield and Clinical Utility of Coronary Angiography Versus Coronary Function Testing in Women With Angina and Nonobstructive Coronary Arteries
Background: Approximately 50% of women referred for invasive coronary angiography have angina and nonobstructive coronary arteries, which includes coronary microvascular dysfunction, vasospastic angina, and other vasomotor disorders. We sought to determine the real‐world diagnostic yield of invasive coronary angiography and coronary function testing in women with angina and nonobstructive coronary arteries. Methods and Results: From 2018 to 2023, we enrolled 198 women who underwent either coronary angiography (CA) alone (n=99) or coronary function testing (CFT; n=99). Mean±SD age was 62±10 years (CA alone) compared with 57±10 years (CFT). Coronary angiography was interpreted as nonobstructive coronary artery disease more frequently after CA alone (79% versus 52%). Of the women who underwent CFT, 82% (N=81) were found to have vasomotor disorders, including coronary microvascular dysfunction (27%), vasospastic angina (32%), mixed coronary microvascular dysfunction/vasospastic angina (16%), endothelial dysfunction (10%; without spasm), elevated resting flow (2%), or symptomatic myocardial bridging (4%). Compared with women undergoing CA alone, medications were changed more frequently after CFT at 24 hours (41% versus 65%; P =0.001) and between 24 hours and 30 days (30% versus 44%; P =0.04) with intensification of antianginal therapy (79% versus 92%; P< 0.0001) and increased use of calcium channel blockers (36% versus 63%; P< 0.0001). Conclusions: Our findings demonstrate that women presenting with suspected ischemic heart disease undergoing CA alone only received an anatomic diagnosis, whereas >80% of women undergoing CFT received a specific diagnosis of a coronary vasomotor disorder and greater intensification of antianginal therapy.
- 9 November 2023
- Published by Elsevier in American Heart Journal
- Vol. 268, 61-67
Opioid prescription and risk of atrial fibrillation in younger veterans
- 9 November 2023
- Published by Elsevier in American Heart Journal
- Vol. 268, 61-67
Opioid prescription and risk of atrial fibrillation in younger veterans
- Open Access
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100915
E-6 | Diagnostic Yield of Invasive Coronary Function Testing Compared With Coronary Angiography Alone in Women With Stable Ischemic Heart Disease
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100915
Open AccessE-6 | Diagnostic Yield of Invasive Coronary Function Testing Compared With Coronary Angiography Alone in Women With Stable Ischemic Heart Disease
- 28 June 2019
- Published by Wiley in Muscle & Nerve
- Vol. 60 (3) , 286-291
Association between pulmonary function and left ventricular volume and function in duchenne muscular dystrophy
Introduction: Duchenne muscular dystrophy (DMD) is characterized by absence of the subsarcolemmal protein dystrophin, present in skeletal muscles and cardiomyocytes. We hypothesized that progressive respiratory and left ventricular (LV) insufficiencies in DMD could be parallel and interrelated phenomena. Methods: We conducted a retrospective chart review of 27 patients with DMD. Our primary objective was to compare the rates of decline between pulmonary function test (PFT) measures (forced expiratory volume in the first second, forced vital capacity, peak expiratory flow rate, maximal inspiratory/expiratory pressure) and echocardiographic estimates of LV end‐diastolic volume and LV ejection fraction. Results: The rates of decline/year of PFTs and LV estimates were not significantly different. Pulmonary function test measures of ventilatory efficiency and strength had strong intercorrelations. Pulmonary function tests and LV estimates had weak but statistically significant correlations. Discussion: A comparable rate of decline in PFTs and LV indices in DMD provides evidence for concurrently progressive deterioration in respiratory and LV functions. Muscle Nerve, 2019
- 28 June 2019
- Published by Wiley in Muscle & Nerve
- Vol. 60 (3) , 286-291
Association between pulmonary function and left ventricular volume and function in duchenne muscular dystrophy
Introduction: Duchenne muscular dystrophy (DMD) is characterized by absence of the subsarcolemmal protein dystrophin, present in skeletal muscles and cardiomyocytes. We hypothesized that progressive respiratory and left ventricular (LV) insufficiencies in DMD could be parallel and interrelated phenomena. Methods: We conducted a retrospective chart review of 27 patients with DMD. Our primary objective was to compare the rates of decline between pulmonary function test (PFT) measures (forced expiratory volume in the first second, forced vital capacity, peak expiratory flow rate, maximal inspiratory/expiratory pressure) and echocardiographic estimates of LV end‐diastolic volume and LV ejection fraction. Results: The rates of decline/year of PFTs and LV estimates were not significantly different. Pulmonary function test measures of ventilatory efficiency and strength had strong intercorrelations. Pulmonary function tests and LV estimates had weak but statistically significant correlations. Discussion: A comparable rate of decline in PFTs and LV indices in DMD provides evidence for concurrently progressive deterioration in respiratory and LV functions. Muscle Nerve, 2019
- 18 June 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 54 (9) , 1422-1430
Diagnostic value of spirometry vs impulse oscillometry: A comparative study in children with sickle cell disease
Background: Spirometry is conventionally used to diagnose airway diseases in children with sickle cell disease (C‐SCD). However, spirometry is difficult for younger children to perform, is effort dependent, and it provides limited information on respiratory mechanics. Impulse oscillometry (IOS) is an effort‐independent pulmonary function test (PFT), which measures total airway resistance (R5Hz) and reactance (AX). IOS could be advantageous without certain limitations of spirometry.Aim: To compare the accuracy of IOS vs spirometry in making the diagnosis of asthma and assessing age‐related pulmonary changes in C‐SCD.Study design: Retrospective chart review.Subject selection: Fifty‐six C‐SCD and thirty‐six controls (asthmatics without SCD) followed at Penn State with PFTs obtained during the initial pulmonary evaluation.Methodology: We grouped C‐SCD into asthmatics and non‐asthmatics based on pre‐referral diagnosis and compared PFTs between two groups. Receiver operating characteristic (ROC) curve analyses and machine learning tools (XGBoost and artificial neural network) were used to rank the spirometry and IOS measures based on their ability to predict a diagnosis of asthma. Robust linear regression was used to analyze association among height/age with various PFT measures.Results: Both ROC and XGBoost indicated that FEF25‐75%, forced expiratory volume in 1 second (FEV1)/forced vital capacity, and R5Hz(%) were the top three predictors for asthma diagnosis. R5Hz(%) and AX had superior bronchodilator response (BDR) than FEV1. IOS parameters had significant association with height/age in C‐SCD (possibly due to the stiff lungs) but not in controls.Conclusion: IOS had advantages over spirometry in C‐SCD because it is feasible in early childhood, provides insights into the pulmonary mechanics, and is more sensitive to detect BDR.
- 18 June 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 54 (9) , 1422-1430
Diagnostic value of spirometry vs impulse oscillometry: A comparative study in children with sickle cell disease
Background: Spirometry is conventionally used to diagnose airway diseases in children with sickle cell disease (C‐SCD). However, spirometry is difficult for younger children to perform, is effort dependent, and it provides limited information on respiratory mechanics. Impulse oscillometry (IOS) is an effort‐independent pulmonary function test (PFT), which measures total airway resistance (R5Hz) and reactance (AX). IOS could be advantageous without certain limitations of spirometry.Aim: To compare the accuracy of IOS vs spirometry in making the diagnosis of asthma and assessing age‐related pulmonary changes in C‐SCD.Study design: Retrospective chart review.Subject selection: Fifty‐six C‐SCD and thirty‐six controls (asthmatics without SCD) followed at Penn State with PFTs obtained during the initial pulmonary evaluation.Methodology: We grouped C‐SCD into asthmatics and non‐asthmatics based on pre‐referral diagnosis and compared PFTs between two groups. Receiver operating characteristic (ROC) curve analyses and machine learning tools (XGBoost and artificial neural network) were used to rank the spirometry and IOS measures based on their ability to predict a diagnosis of asthma. Robust linear regression was used to analyze association among height/age with various PFT measures.Results: Both ROC and XGBoost indicated that FEF25‐75%, forced expiratory volume in 1 second (FEV1)/forced vital capacity, and R5Hz(%) were the top three predictors for asthma diagnosis. R5Hz(%) and AX had superior bronchodilator response (BDR) than FEV1. IOS parameters had significant association with height/age in C‐SCD (possibly due to the stiff lungs) but not in controls.Conclusion: IOS had advantages over spirometry in C‐SCD because it is feasible in early childhood, provides insights into the pulmonary mechanics, and is more sensitive to detect BDR.